3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
8
Leukemia, Myeloid, Chronic-Phase
7
Burkitt Lymphoma
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Philadelphia Chromosome
2
Pancreatic Neoplasms
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Glioma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Interventions
pembrolizumab
3
Carboplatin
3
selpercatinib
2
durvalumab
2
Pemetrexed
2
Cisplatin
2
taletrectinib
1
sotorasib
1
repotrectinib
1
pralsetinib
1
ceralasertib
1
Telescopes
1
Radiosurgery
1
Paclitaxel
1
Gemcitabine
1
Gefitinib
1
Erlotinib Hydrochloride
1
Bevacizumab
1
AZD3759
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Respiratory Tract Diseases
×
Dasatinib
×
1 year
×
Clear all
No trials found.